93 782 (Tamoxifen 20 mg)

Pill imprint 93 782 has been identified as Tamoxifen citrate 20 mg.

Tamoxifen is used in the treatment of breast cancer, adjuvant; breast cancer; breast cancer, metastatic; breast cancer, male; breast cancer, palliative (and more), and belongs to the drug classes hormones/antineoplastics, selective estrogen receptor modulators. There is positive evidence of human fetal risk during pregnancy. Tamoxifen 20 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for 93 782 (Tamoxifen 20 mg)

Tamoxifen citrate 20 mg 93 782
Tamoxifen citrate 20 mg 93 782
Tamoxifen citrate
Imprint:
93 782
Strength:
20 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
Hormones/antineoplastics
Selective estrogen receptor modulators
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-0782
Inactive Ingredients:
croscarmellose sodium
hypromellose 2910 (5 mPa.s)
lactose monohydrate
magnesium stearate
polyethylene glycol 400
povidone k30
corn starch
titanium dioxide
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-4287 Physicians Total Care Inc (repackager)
54569-5857 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Suffering from sore knees? Assess your knee pain with our interactive tool. Click Here

Close
Hide
(web4)